Tate, S.;                     Nishikimi, K.;                     Matsuoka, A.;                     Otsuka, S.;                     Shozu, M.    
        Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin. Cancers 2021, 13, 640.
    https://doi.org/10.3390/cancers13040640
    AMA Style
    
                                Tate S,                                 Nishikimi K,                                 Matsuoka A,                                 Otsuka S,                                 Shozu M.        
                Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin. Cancers. 2021; 13(4):640.
        https://doi.org/10.3390/cancers13040640
    
    Chicago/Turabian Style
    
                                Tate, Shinichi,                                 Kyoko Nishikimi,                                 Ayumu Matsuoka,                                 Satoyo Otsuka,                                 and Makio Shozu.        
                2021. "Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin" Cancers 13, no. 4: 640.
        https://doi.org/10.3390/cancers13040640
    
    APA Style
    
                                Tate, S.,                                 Nishikimi, K.,                                 Matsuoka, A.,                                 Otsuka, S.,                                 & Shozu, M.        
        
        (2021). Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin. Cancers, 13(4), 640.
        https://doi.org/10.3390/cancers13040640